Corticosteroids are essential when treating patients with giant cell arteritis or polymyalgia rheumatica

Author：

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.28, Iss.4, 2012-04, pp. : 11-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Polymyalgia Rheumatica and Giant Cell Arteritis in Older Patients: Diagnosis and Pharmacological Management

By Schmidt Jean Warrington Kenneth J.

Drugs & Aging, Vol. 28, Iss. 8, 2011-08 ,pp. : 651-666

Adis International

Access to resources Recommend Favorite

Polymyalgia rheumatica and its links with giant cell arteritis

By Charlton Rodger

Clinical Medicine, Vol. 8, Iss. 5, 2008-10 ,pp. : 498-501

Royal College Of Physicians

Access to resources Recommend Favorite

Giant Cell Arteritis and Polymyalgia Rheumatica: Pathophysiology and Management

By Gonzalez-Gay Miguel A.

Drugs & Aging, Vol. 23, Iss. 8, 2006-01 ,pp. : 627-649

Adis International

Access to resources Recommend Favorite

Influenza virus vaccine: Giant cell arteritis with polymyalgia rheumatica in an elderly patient: case report

Reactions Weekly, Vol. 1, Iss. 1385, 2012-01 ,pp. : 26-26

Adis International

Access to resources Recommend Favorite

Torsades de Pointes in Patients with Polymyalgia Rheumatica

Current Pharmaceutical Design, Vol. 24, Iss. 3, 2018-04 ,pp. : 323-340

Bentham Science Publishers

Access to resources Recommend Favorite